Literature DB >> 1770305

A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans.

F Czubayko1, B Beumers, S Lammsfuss, D Lütjohann, K von Bergmann.   

Abstract

A simple and precise micro-method for measurement of daily fecal excretion of neutral and acidic sterols has been developed which utilizes sitostanol (24-ethyl-5 alpha-cholestane-3 beta-ol) as fecal flow and recovery marker. Extractions of sterols were performed from 50 microliters of fecal homogenate (feces-water 1:1), and analyses of neutral and acidic sterols were carried out by gas-liquid chromatography. The method is sensitive, precise, and easy to perform; the intra-assay variability yielded coefficients of variations of 1.9% and 3.5% (n = 6) for neutral and acidic sterols, respectively. The results from this method were compared with those obtained with the standard fecal flow marker chromic oxide. The correlation coefficients between the two markers were compared in 16 subjects and were 0.938 and 0.998 for excretion of neutral sterols and acidic sterols, respectively. Comparison of the fecal excretion of neutral and acidic sterols in 12 subjects determined from frozen samples and aliquots (approximately 1 g) sent by ordinary mail to the laboratory (transport time 1 to 5 days) gave identical results using sitostanol as fecal flow marker (818 +/- (SEM) 85 mg/day vs. 838 +/- 89 mg/day for neutral sterols and 417 +/- 59 mg/day vs. 414 +/- 60 mg/day for acidic sterols). The new micro-method is ideally suited for research laboratories in need of a simple, accurate, inexpensive, and high through-put method for measuring daily fecal excretion of neutral and acidic sterols, as well as total cholesterol synthesis, and can be performed on an outpatient basis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1770305

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  18 in total

1.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

Authors:  Emil M deGoma; Rolando L deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

3.  Psyllium, not pectin or guar gum, alters lipoprotein and biliary bile acid composition and fecal sterol excretion in the hamster.

Authors:  E A Trautwein; D Rieckhoff; A Kunath-Rau; H F Erbersdobler
Journal:  Lipids       Date:  1998-06       Impact factor: 1.880

Review 4.  Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux.

Authors:  Carlos G Santos-Gallego; Chiara Giannarelli; Juan José Badimón
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

Review 5.  Sitosterolemia--a rare disease. Are elevated plant sterols an additional risk factor?

Authors:  T Sudhop; K von Bergmann
Journal:  Z Kardiol       Date:  2004-12

6.  Determination of Fecal Sterols Following a Diet with and without Plant Sterols.

Authors:  María Cuevas-Tena; Amparo Alegría; María Jesús Lagarda
Journal:  Lipids       Date:  2017-09-06       Impact factor: 1.880

7.  Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans.

Authors:  Xiaobo Lin; Susan B Racette; Michael Lefevre; Lina Ma; Catherine Anderson Spearie; Karen Steger-May; Richard E Ostlund
Journal:  Circulation       Date:  2011-07-18       Impact factor: 29.690

Review 8.  Future therapeutic directions in reverse cholesterol transport.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

9.  Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients.

Authors:  Jorge Herrera; Ludwig Amigo; Constanze Husche; Carlos Benítez; Silvana Zanlungo; Dieter Lütjohann; Juan Francisco Miquel; Flavio Nervi
Journal:  Lipids Health Dis       Date:  2009-12-08       Impact factor: 3.876

10.  Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.

Authors:  Thomas Sudhop; Michael Reber; Diane Tribble; Aditi Sapre; William Taggart; Patrice Gibbons; Thomas Musliner; Klaus von Bergmann; Dieter Lütjohann
Journal:  J Lipid Res       Date:  2009-04-20       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.